Evaluating Care for Patients with Schizophrenia-like Disorders in Their Environment
Interest of the Tool: Evaluation of Specific Care in an Ecological Environment for Patients Suffering From Schizophrenia-like Disorders
This study is trying to see if a new questionnaire can help understand the daily needs of people with schizophrenia-like disorders by visiting them at home to improve their care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 56 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Henri Laborit Academic / other |
| Locations | 1 site (Poitiers) |
| Trial ID | NCT05349513 on ClinicalTrials.gov |
What this trial studies
This study evaluates the ecological environment of patients suffering from schizophrenia-like disorders using a new questionnaire called ESSME. The approach involves home visits to administer the questionnaire, allowing for a more personalized assessment of the patients' daily concerns and needs. Participants will be involved for a duration of six months, with multiple visits to gather data at different points in time. The goal is to improve care by setting objectives that are closely aligned with the patients' real-life situations.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 to 65 with a diagnosis of schizophrenia or schizoaffective disorder who are receiving care in a rehabilitation center.
Not a fit: Patients outside the age range of 18 to 65, those with associated neurodevelopmental disorders, or individuals unable to participate in home visits may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the quality of care for patients with schizophrenia-like disorders by tailoring interventions to their specific ecological contexts.
How similar studies have performed: While the specific use of the ESSME questionnaire is novel, similar approaches evaluating ecological factors in mental health care have shown promise in enhancing patient outcomes.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * man or woman aged 18 to 65 inclusive; * diagnosis of schizophrenia or schizoaffective disorder according to the Diagnostic and Statistical Manual of Mental Disorders version number 5 (DSM-V) criteria; * patient receiving care in a Center for Rehabilitation and Intersectoral Therapeutic Activities (CREATIV); * person who consented to the study; * affiliate or beneficiary of a social security scheme. Exclusion Criteria: * patient aged under 18 or over 65; * pregnant or breastfeeding women; * person unable or unwilling to receive a home visit; * person not consenting to the study; * presence of a diagnosis of an associated neurodevelopmental disorder; * presence of a diagnosis of dementia or associated neurodegenerative process; * person with a level of French language insufficient to understand the items.
Where this trial is running
Poitiers
- Centre Hospitalier Henri Laborit — Poitiers, France (Recruiting)
Study contacts
- Study coordinator: Carole WANGERMEZ
- Email: carole.wangermez@ch-poitiers.fr
- Phone: +33 5 49 38 00 19
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.